Publications
09.11.2022
ISPOR 2022 Plenary Session 3 - Integrating Data

Our experts provide a detailed summary of Plenary Session 2 at ISPOR 2022 on innovative methods for ...

Read more
Publications
08.11.2022
ISPOR 2022 Plenary Session 2 - Real-World Research

Our experts provide a detailed summary of Plenary Session 2 at ISPOR 2022 on real-world patient-cent...

Read more
Publications
07.11.2022
ISPOR 2022 Plenary Session 1 - HTA and Regulation

Our experts provide a detailed summary of Plenary Session 1 at ISPOR 2022 on the Convergence of HTA ...

Read more
Publications
19.10.2022
ISPOR 2022: Changing landscape of Orphan Drug Reim...

We compare the rates of positive reimbursement decisions in England and EU4 for orphan drugs approve...

Read more
Publications
12.10.2022
ISPOR 2022: Do manufacturers still see value in su...

Our research is aimed at identifying trends in terminated appraisals in relation to therapeutic area...

Read more
Publications
12.10.2022
ISPOR 2022: Is International Reference Pricing app...

In our research, we determine how consistently IRP is applied in pharmaceutical price re-evaluation ...

Read more
Publications
12.10.2022
ISPOR 2022: Could Netflix Based Subscription Model...

We analyse subscription-based agreements for antibiotics in Europe to understand how it may address ...

Read more
Publications
12.10.2022
ISPOR 2022: Comparing and contrasting Early Access...

We've researched early access programmes across the UK and EU4 to establish the eligibility criteria...

Read more
Publications
28.09.2022
ISPOR 2022: Does NICE’s Sta process effectively ...

We investigate Single Technology Appraisals (STAs) conducted by the National Institute for Health an...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.